Kiora Pharmaceuticals Inc... (KPRX)
NASDAQ: KPRX
· Real-Time Price · USD
2.94
0.41 (16.21%)
At close: Aug 15, 2025, 2:13 PM
Kiora Pharmaceuticals Fail-to-Deliver
Total FTD Shares
22.7K
Below Average
FTD / Avg. Volume
4.79%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Kiora Pharmaceuticals Inc. has
22,697
shares failed to deliver, representing 4.79%
of the average daily volume of
474,100
shares. Over the past year, the monthly average FTD is
11,544
shares, with the current level 97% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 3.08 | 22.7K | +693.05% |
| Jun 25, 2025 | 3.03 | 2.86K | +4834.48% |
| May 30, 2025 | 2.98 | 58 | -98.90% |
| Apr 29, 2025 | 3.29 | 5.26K | +6395.06% |
| Mar 31, 2025 | 3.01 | 81 | -80.39% |
| Feb 28, 2025 | 3.25 | 413 | +778.72% |
| Jan 31, 2025 | 4.03 | 47 | +4.44% |
| Dec 20, 2024 | 3.27 | 45 | -97.84% |
| Nov 27, 2024 | 3.57 | 2.08K | -91.17% |
| Oct 31, 2024 | 3.62 | 23.62K | +2295.33% |
| Sep 27, 2024 | 3.43 | 986 | +804.59% |
| Aug 30, 2024 | 3.7 | 109 | -78.20% |
| Jul 30, 2024 | 4.39 | 500 | -55.56% |
| Jun 28, 2024 | 4.2 | 1.13K | -21.77% |
| May 28, 2024 | 4.8 | 1.44K | -9.73% |
| Apr 30, 2024 | 4.52 | 1.59K | -75.46% |
| Mar 28, 2024 | 6.35 | 6.49K | +107.68% |
| Feb 28, 2024 | 6.12 | 3.13K | -36.58% |
| Jan 22, 2024 | 4.94 | 4.93K | +689.90% |
| Dec 29, 2023 | 4.7 | 624 | -89.19% |
| Nov 30, 2023 | 4.66 | 5.77K | +19143.33% |
| Oct 31, 2023 | 5.31 | 30 | -98.86% |
| Sep 29, 2023 | 5.11 | 2.63K | +9.24% |
| Aug 11, 2023 | 4.95 | 2.4K | +206.51% |
| Jul 27, 2023 | 5.31 | 784 | -83.59% |
| Jun 29, 2023 | 6.02 | 4.78K | +88.37% |
| May 31, 2023 | 18.81 | 2.54K | -37.33% |
| Apr 28, 2023 | 39.96 | 4.05K | +20140.00% |
| Mar 31, 2023 | 30.06 | 20 | -88.30% |
| Feb 28, 2023 | 40.05 | 171 | -91.05% |
| Jan 31, 2023 | 31.77 | 1.91K | n/a |